DXP Enterprises has seen nearly 200% stock growth in the past year, driven by acquisitions and diversification. See why I rate DXPE stock as a hold.
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight ...
AMD’s revenue surged 14% in 2024, with its AI data center business contributing significantly to this growth, reaching over ...
Domo's Q3 2025 results beat expectations, although growth remains very slow. Nevertheless, I am upgrading the stock to a ...
18h
Hosted on MSNThis Magnificent Seven Tech Rebounds After Hitting New Low In 2025; Is Microsoft Stock A Buy In February?When a stock breaks out of a well-formed base, you normally want to see the Relative Strength Rating exceed 80.
StepStone Group Inc. has shown stellar performance since its IPO in 2020, with significant growth in AUM and fee-related ...
Another element of risk concerns the over-reliance of Blaize to the automotive industry. A global slowdown in automotive ...
23h
Investor's Business Daily on MSNDow Jones Futures Rise, Market Eyes Highs; New Tesla Model Y Deliveries Sped UpDow Jones futures rose slightly Tuesday morning, along with S&P 500 futures and Nasdaq futures. Tesla moved up new Model Y ...
Our methodology consistently identified pivotal moments in Tesla over the last several months. Read why there is immediately ...
1d
MarketBeat on MSNBeyond DeepSeek: 4 Chinese ETFs for AI & Tech ExposureAs Chinese artificial intelligence company DeepSeek continues to challenge American chip manufacturer NVIDIA for chip ...
We recently compiled a list of the 10 Fastest Growing Mutual Funds in 2025. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results